As of November 6, 2026, Silo Pharma, Inc. is a publicly traded company (Nasdaq: SILO); its largest reported holder is Mitchell P. Kopin, with 9.99% on Schedule 13G/A of August 13, 2026, then AdvisorShares Trust (6.69%). The largest insider holding is Eric Weisblum, the chief executive and a director, with 216,932 shares (13.7% of shares outstanding), per Form 4 of December 16, 2025 (Schedule 13G/A, August 13, 2026).
Is this your company?
About to sign with, pay or invest in Silo Pharma, Inc.? See the free Snapshot first.
Free to see. No signup.
Is Silo Pharma, Inc. a real, registered company?
- Silo Pharma, Inc. files with the SEC under CIK 1514183 (its SEC filings).
- Its shares are listed under the ticker SILO on Nasdaq (SEC company record).
- Incorporated in Nevada; business address in Sarasota, Florida, as its SEC filings state.
- Court and bankruptcy records: see Before you sign or pay below.
Before you sign or pay
- Court and bankruptcy: No federal court case or bankruptcy filing found under Silo Pharma, Inc. in our court records and SEC 8-K records (as of 2026-11-06).
- Ownership: 5%+ holders are reported on Schedule 13D or 13G; the latest names Mitchell P. Kopin (filed 2026-08-13).
Who are Silo Pharma, Inc.'s owners and officers?
Silo Pharma, Inc.: incorporated in Nevada; business address in Sarasota, Florida; industry Pharmaceutical Preparations (Schedule 13G/A, 2026-08-13).
Officers and directors, each with the role and the filing that names them:
- : Executive Officer, Director (Form D, 2026-07-14)
- : Executive Officer (Form D, 2026-07-14)
- : Director (Form D, 2026-07-14)
- : Director (Form D, 2026-07-14)
- : Director (Form D, 2026-07-14)
| Report | Holder | Share |
|---|---|---|
| Schedule 13G/A, 2026-08-13 | Mitchell P. Kopin | 9.99% |
| Schedule 13G, 2026-07-08 | Advisorshares Trust | 6.69% |
| Schedule 13G/A, 2026-02-17 | Anson Funds Management LP | 4.9% |
| Schedule 13G/A, 2026-02-13 | Seg Opportunity Fund, LLC | 0% |
| Schedule 13G/A, 2026-02-13 | Mitchell P. Kopin | 9.99% |
| Schedule 13G, 2025-11-14 | Anson Funds Management LP | 7.2% |
| Schedule 13G/A, 2025-11-07 | Mitchell P. Kopin | 9.99% |
| Schedule 13G, 2025-10-03 | Seg Opportunity Fund, LLC | 7.1% |
| Schedule 13G/A, 2025-08-12 | Mitchell P. Kopin | 9.99% |
Questions about who owns Silo Pharma, Inc.
Who owns Silo Pharma, Inc.?
On this page, 2 holders' latest ownership filings report 5% or more of Silo Pharma, Inc.: Mitchell P. Kopin (9.99%, Schedule 13G/A, filed 2026-08-13) and Advisorshares Trust (6.69%, Schedule 13G, filed 2026-07-08).
Who are the largest shareholders of Silo Pharma, Inc.?
By the share each holder's latest filing reports, the largest holders of Silo Pharma, Inc. on this page are Mitchell P. Kopin (9.99%) and Advisorshares Trust (6.69%).
When did Mitchell P. Kopin buy into Silo Pharma, Inc.?
The filings give report dates, not purchase dates. The earliest filing from Mitchell P. Kopin on this page is the Schedule 13G/A, filed 2025-08-12, reporting 9.99%; its latest, Schedule 13G/A filed 2026-08-13, reports 9.99%. That earliest filing is itself an amendment, which updates an earlier report.
Is this an audit or a full list?
Neither. The ownership list on this page covers only Schedule 13D and 13G filings, which holders make once they own 5% or more of a class of shares (an amendment can report a stake that has since fallen below 5%); 9 such filings are shown here. It is not an audit and not a full cap table: holders who never reached 5% are not listed, and a stake can change after its latest filing.
Want the whole picture on Silo Pharma, Inc.?
Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News
A Full Report on Silo Pharma, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Silo Pharma, Inc. covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
19 cited sources found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Which insiders own Silo Pharma, Inc. shares?
Directors, officers and holders of 10% or more report their shares on Forms 3, 4 and 5. Each line is the latest such report, largest holding first.
- , the chief executive and a director: 216,932 shares (13.7% of shares outstanding) (Form 4, 2025-12-16).
Shares outstanding: 1,588,250 as of 2026-08-13, from the company's latest SEC cover page.
How much has Silo Pharma, Inc. raised?
| Filed | Sold | Offered |
|---|---|---|
| Form D, 2026-07-14 | $4M | $4M |
| Form D, 2024-08-02 | $2.30M | $2.30M |
| Form D, 2024-06-11 | $2.08M | $2.08M |
Latest IPO step: Silo Pharma, Inc. filed to go public (S-1, 2025-10-29).
IPO filings: S-1, 2025-10-29, 424B4, 2025-05-16, S-1/A, 2025-05-09, S-1/A, 2025-04-29, S-1, 2025-04-25; ticker SILO on Nasdaq Capital Market.
Keep reading
More on Silo Pharma, Inc. and the records around it.
Silo Pharma, Inc. elsewhere on the record
- 5%+ stake filings Aug 2026
- Company profile and every filing Jul 2026
- Form D filing Jul 2026
Companies that share a holder
- SEG Opportunity Fund, LLC also filed stake reports on 4 other companies: Volato Group, Inc. (Jul 2026), AUDDIA INC. (Apr 2026)
- AdvisorShares Trust also filed stake reports on 8 other companies: Neuphoria Therapeutics Inc. (Oct 2026), PSYENCE BIOMEDICAL LTD. (Oct 2026), Enveric Biosciences, Inc. (Jan 2026)
- Anson Funds Management LP also filed stake reports on 36 other companies: 22nd Century Group, Inc. (Aug 2026), Imperial Petroleum Inc. (Aug 2026), K Wave Media Ltd. (Aug 2026)
Related pages
Funding and filing history5%+ holders
Filings, cases and notices link to their records. A not-found line names the records searched; it is not proof of absence.
Not for employment, credit, insurance or tenancy decisions.
Cite this page
https://mentionfox.com/who-owns/silo-pharma-inc